MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.
MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test
- Post author:
- Post published:September 17, 2024
- Post category:uncategorized